Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)

Hossein Gorji, Noé Stauffer, Ivan Lunati, Alexa Caduff, Martin Bühler, Doortje C. Engel, Ho‐Ryun Chung, Orestis Loukas, Sabine Feig, Harald Renz

This research paper, published in early 2022, provides a timely modeling analysis of the Omicron (B.1.1.529) wave's impact on the healthcare systems of Germany and Switzerland. By utilizing age-stratified compartmental models, the authors explore whether the massive surge in cases would inevitably lead to a collapse of hospital and ICU capacity.

TL;DR

Despite the unprecedented number of infections driven by the Omicron variant, the study predicts that healthcare systems in Germany and Switzerland were unlikely to be overwhelmed. This "decoupling" of case numbers from severe outcomes is attributed to Omicron’s lower intrinsic severity and the continued effectiveness of vaccines against hospitalization, even as protection against infection wanes.

What Problem Does This Paper Address?

In early 2022, public health officials faced a paradox: Omicron was far more transmissible than previous variants, leading to record-breaking daily case counts, yet early data from the UK and South Africa suggested it might be "milder."

The central challenge for policymakers was determining if the sheer volume of infections would still saturate hospitals through "brute force" numbers. This paper seeks to quantify that risk for Germany and Switzerland, accounting for their specific vaccination rates, vaccine types (mRNA vs. vector-based), and social mixing patterns.

Methods

The authors employed a Susceptible-Infected-Removed (SIR) type compartmental model, which is a standard epidemiological tool, but they added several layers of refinement:

  • Age Stratification: The population was divided into 16 age groups (from 1-5 to 75+) to account for different social behaviors and clinical risks.
  • Vaccination Dynamics: The model distinguishes between unvaccinated, vaccinated, and recently recovered individuals. Crucially, it incorporates waning immunity and the specific efficacy of different vaccine mixes (BNT162b2, mRNA-1273, and ChAdOx1).
  • Variant Co-existence: The model accounts for a transition period where Delta (10%) and Omicron (90%) circulated simultaneously.
  • Social Mixing: It uses country-specific contact matrices to simulate how different age groups interact in various settings.

Datasets

The study integrated several public and peer-reviewed data sources:

  • Epidemiological Data: Official COVID-19 statistics from the Swiss Federal Office of Public Health (FOPH) and the German Robert-Koch-Institute (RKI).
  • Contact Matrices: Age-specific social mixing data from Prem et al. (2017), which covers 152 countries.
  • Clinical Parameters: Vaccine efficacy and variant severity data pulled from a wide range of early-2022 technical briefings (e.g., UK Health Security Agency) and clinical studies.

Key Insights and Ideas

  • The Decoupling Effect: The most significant insight is the mathematical confirmation of "decoupling." Because Omicron's hospitalization rate is roughly 56% lower than Delta's and the average hospital stay is much shorter (1.5 days vs. 14 days), the healthcare system can tolerate a much higher "incidence ceiling" than in previous waves.
  • Heterogeneity and Attack Rates: The authors found that Switzerland’s contact patterns are more heterogeneous than Germany’s. In epidemiology, more "clumpy" or heterogeneous networks often result in lower overall attack rates during an epidemic, which partially explains differences in their projected peaks.
  • Vaccine Mix Matters: The study notes a 20% difference in vaccine efficacy against infection between the two countries, attributed to the specific mix of vaccine brands used. Switzerland’s reliance on mRNA vaccines with longer-term efficacy provided slightly stronger protection.
  • The "Staffing" Threat: A key "aha moment" is the realization that the primary threat to healthcare might not be bed capacity, but workforce depletion. With 5-10% of the population potentially infected in a single week, the risk of medical staff being quarantined simultaneously poses a significant operational risk.

Key Results

  • ICU Stability: Under the "worst-case" scenario ($R_e = 1.8$), ICU occupancy was projected to remain below critical thresholds (400-500 beds in Switzerland; 7,000-8,000 in Germany).
  • Infection Peaks: In the most aggressive scenario, the model expected 5-10% of the total population to be infected within a single week.
  • Efficacy Stats: The overall efficacy of the vaccine mix against hospitalization was estimated at approximately 0.6 for Germany and 0.65 for Switzerland.
  • Severity Reduction: The model assumed a 67% reduction in the probability of ICU admission for Omicron compared to Delta across all age groups.

Limitations and Future Work

The authors acknowledge several limitations inherent in predictive modeling:

  • Parameter Uncertainty: Early data on Omicron severity and vaccine waning were still evolving at the time of writing.
  • Behavioral Assumptions: The model assumes mitigation measures (like masks or social distancing) remain constant, but public behavior often shifts in response to rising case numbers.
  • Long-COVID: The study focuses strictly on acute healthcare demand (hospital beds) and does not account for the long-term burden of "Long-COVID" or the socio-economic toll of mass infections.
  • Future Variants: While the framework is adaptable, it cannot predict the characteristics of future variants that might escape current immunity even more effectively.

Summary updated

Abstract

In January 2022, after the implementation of broad vaccination programs, the Omicron wave was propagating across Europe. There was an urgent need to understand how population immunity affects the dynamics of the COVID-19 pandemic when the loss of vaccine protection was concurrent with the emergence of a new variant of concern. In particular, assessing the risk of saturation of the healthcare systems was crucial to manage the pandemic and allow a transition towards the endemic course of SARS-CoV-2 by implementing more refined mitigation strategies that shield the most vulnerable groups and protect the healthcare systems. We investigated the epidemic dynamics by means of compartmental models that describe the age-stratified social-mixing and consider vaccination status, type, and waning of the efficacy. In response to the acute situation, our model aimed at (i) providing insight into the plausible scenarios that were likely to occur in Switzerland and Germany in the midst of the Omicron wave, (ii) informing public health authorities, and (iii) helping take informed decisions to minimize negative consequences of the pandemic. Despite the unprecedented numbers of new positive cases, our results suggested that, in all plausible scenarios, the wave was unlikely to create an overwhelming healthcare demand; due to the lower hospitalization rate and the effectiveness of the vaccines in preventing a severe course of the disease. This prediction came true and the healthcare systems in Switzerland and Germany were not pushed to the limit, despite the unprecedentedly large number of infections. By retrospective comparison of the model predictions with the official reported data of the epidemic dynamic, we demonstrate the ability of the model to capture the main features of the epidemic dynamic and the corresponding healthcare demand. In a broader context, our framework can be applied also to endemic scenarios, offering quantitative support for refined public health interventions in response to recurring waves of COVID-19 or other infectious diseases.
BibTeX
@inproceedings{gorji2023projection,
  author = {Hossein Gorji and Noé Stauffer and Ivan Lunati and Alexa Caduff and Martin Bühler and Doortje C. Engel and Ho‐Ryun Chung and Orestis Loukas and Sabine Feig and Harald Renz},
  title = {{Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)}},
  booktitle = {Epidemics},
  year = {2023},
  doi = {10.1016/j.epidem.2023.100680},
}
Figure